4.10.19.3Vertical

Interventional Pain Management Clinics

Pain physicians performing spinal injections and nerve blocks.

Market snapshot

These figures describe Pain Management & Interventional Pain (4.10.19), the segment that Interventional Pain Management Clinics sits within. They are not figures for Interventional Pain Management Clinics on its own.

FragmentationConsolidatingEstimate

Within Offices of Physicians (NAICS 621111); the Census Bureau does not split physician offices by specialty, so pain management is not separately sized.

Business model & economics

Revenue model

Procedure-driven interventional-pain reimbursement

Key economics

Recurring revenue
Moderate

chronic-pain management recurs

EBITDA margin
18–28% with ancillaries
Capex intensity
Moderate

Characteristics

  • Shift toward interventional, non-opioid pain treatment.
  • ASC and neuromodulation ancillaries drive economics.
  • Regulatory sensitivity around opioid prescribing.

M&A deal context

Deal activityModerate

Who’s acquiring

  • PE-backed pain platforms
  • Specialty MSO consolidators
  • ASC-aligned acquirers

What’s driving deals

  • Roll-up for interventional and ASC economics.
  • Chronic-pain and non-opioid-treatment demand.
  • Regulatory scrutiny shaping the specialty.

Find Interventional Pain Management Clinics acquisition targets

Search Acquisera’s index for companies classified under Interventional Pain Management Clinics (4.10.19.3) and build a targeted deal pipeline.

Search companies